admin

As negotiations for a cease-fire between Israel and Hamas approach a decisive moment, the toll of the conflict continues to grow. Today, the Israeli military reported five soldiers were killed in Beit Hanoun, northern Gaza,…

Rep. Anna Paulina Luna, R-Fla., is unveiling a new set of bills that could have child sexual predators facing the death penalty. ‘If you are raping someone, if you’re molesting someone, you are essentially murdering…

Pete Hegseth is set to take the hot seat before the Senate Armed Services Committee on Tuesday in a hearing that is sure to break out into fireworks.  President-elect Donald Trump nominated Hegseth to shake…

Zinc was among the best-performing base metals in 2024. It experienced a 13 percent gain, rising from US$2,621 per metric ton (MT) to US$2,979 by the end of the year. Like copper, zinc faced concentrate…

As data breaches and cyberattacks rise, cybersecurity exchange-traded funds (ETFs) are gaining traction. The term cybersecurity originated in 1989, and today is defined as the measures taken to protect a computer or computer system against…

Basin Energy (BSN:AU) has announced Scandinavian Exploration and Uranium Policy Update Download the PDF here. This post appeared first on investingnews.com

Ernest Mast, President and Managing Director, Cygnus Metals Ltd. (TSXV: CYG) (‘Cygnus Metals’ or the ‘Company’), and his team, joined Robert Peterman, Chief Commercial Officer, Toronto Stock Exchange (TSX), to open the market to celebrate…

Mali’s government has begun seizing gold stockpiled at Barrick Gold’s (TSX:ABX,NYSE:GOLD) Loulo-Gounkoto mine, enforcing a provisional order issued last week amid a dispute over changes to the nation’s mining rules. The seizure was confirmed by…

The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ahead after declining earnings in recent years. According to ZS consultant Cody Powers, lower interest…

Today’s pharmaceutical market is facing the challenges of inflation, government-imposed drug price caps and waning demand for COVID-19 vaccines. However, the industry’s major underlying drivers — higher rates of cancer and chronic diseases — are…